In a seed investment round led by Capital 2B, a deeptech-focused fund supported by Info Edge and Temasek with participation from Capital-A and Anicut Capital, the deeptech manufacturing firm Leumas has raised $2.2 million.
According to a news statement from Leumas, the money will be utilized to increase its R&D capacity, scale its on-demand manufacturing infrastructure, and start pilot projects of factories specifically designed for pharmaceutical and wellness companies.
Leumas, which was co-founded in 2016 by Nitesh K. and Subhajit Biswas, provides factory-as-a-service and on-demand manufacturing methods for pharmaceutical and wellness businesses. From development to commercial production, its software-defined, modular robot factories significantly enhance manufacturing and business outcomes. It helps brands scale rapidly, maintain quality, and lower risk by fusing automation, software intelligence, and research and development.
Leumas claims that their main offering is cyber-physical manufacturing technology, which consists of software-driven, modular production lines that combine autonomous operations, vision-based quality systems, and AI-led robotics to guarantee both regulatory compliance and maximum production productivity.
According to market research, by 2030, the pharmaceutical and wellness outsourced development and manufacturing industry is projected to grow to a value of over $400 billion.
Leumas asserts that it has co-developed its manufacturing solution with top wellness brands over the past year and has assisted in the expansion of over 120 items throughout MENA, the US, and India. Additionally, it has agreements with leading pharmaceutical and food research organizations to use its modular manufacturing technology to construct specific factory capacities.
